AVASTIN

ਉਤਪਾਦ ਝਲਕ

About AVASTIN

AVASTIN is a prescription medication containing the active ingredient Bevacizumab, a recombinant humanized monoclonal antibody. It is used to treat various types of cancer, including colorectal, lung, brain, kidney, and breast cancer.

Key Benefits & Uses

• Treatment of metastatic colorectal cancer in combination with 5-fluorouracil-based chemotherapy.
• Treatment of non-squamous non-small cell lung cancer in combination with carboplatin and paclitaxel.
• Treatment of recurrent glioblastoma in combination with irinotecan.
• Treatment of metastatic renal cell carcinoma in combination with interferon alfa.
• Treatment of HER2-negative metastatic breast cancer in combination with paclitaxel.

Active Ingredient & Action

Bevacizumab works by inhibiting angiogenesis, the process by which new blood vessels form from pre-existing ones. It binds to vascular endothelial growth factor (VEGF), a protein that promotes angiogenesis, thereby preventing the formation of new blood vessels that feed tumor growth.

Important Notes

AVASTIN is available by prescription only and should be used under the guidance of a qualified healthcare professional. Common side effects include hypertension, proteinuria, and gastrointestinal perforation. Patients with a history of hemoptysis or recent gastrointestinal bleeding should not receive AVASTIN. It is essential to follow the recommended dosing schedule and to report any adverse reactions to your healthcare provider.